2025
Journal - Research Article
Alexander, P. H., Davenport, A. P., Kelly, E., Gibb, A. J., Mathie, A. A., Peach, C. J., … Garelja, M. L., … Glass, M., … Hay, D. L., … Zaidman, N. (2025). The concise guide to Pharmacology 2025/26: G protein-coupled receptors. British Journal of Pharmacology, 182, S24-S151. doi: 10.1111/bph.70230
Garelja, M. L., Rees, T. A., & Hay, D. L. (2025). Calcitonin gene-related peptide and headache: Comparison of two commonly used assay kits highlights the perils of measuring neuropeptides with enzyme-linked immunosorbent assays. Headache. Advance online publication. doi: 10.1111/head.15011
Tasma, Z., Garelja, M. L., Jamaluddin, A., Alexander, T. I., & Rees, T. A. (2025). Where are we now? Biased signalling of Class B G protein-coupled receptor-targeted therapeutics. Pharmacology & Therapeutics, 270, 108846. doi: 10.1016/j.pharmthera.2025.108846
2024
Journal - Research Article
Garelja, M. L., Alexander, T. I., Walker, C. S., & Hay, D. L. (2024). Extracellular bimolecular fluorescence complementation for investigating membrane protein dimerization: A proof of concept using class B GPCRs. Bioscience Reports, 44, BSR20240449. doi: 10.1042/bsr20240449
Babych, M., Garelja, M. L., Nguyen, P. T., Hay, D. L., & Bourgault, S. (2024). Converting the amyloidogenic islet amyloid polypeptide into a potent nonaggregating peptide ligand by side chain-to-side chain macrocyclization. Journal of the American Chemical Society, 146, 25513-25526. doi: 10.1021/jacs.4c05297
Rees, T. A., Tasma, Z., Garelja, M. L., O'Carroll, S. J., Walker, C. S., & Hay, D. L. (2024). Calcitonin receptor, calcitonin gene-related peptide and amylin distribution in C1/2 dorsal root ganglia. Journal of Headache & Pain, 25, 36. doi: 10.1186/s10194-024-01744-z
Mazzini, G., Le Foll, C., Boyle, C. N., Garelja, M. L., Zhyvoloup, A., Miller, M. E. T., Hay, D. L., … Lutz, T. A. (2024). The processing intermediate of human amylin, pro-amylin(1–48) has in vivo and in vitro bioactivity. Biophysical Chemistry, 308, 107201. doi: 10.1016/j.bpc.2024.107201
Garelja, M. L., Alexander, T. I., Bennie, A., Nimick, M., Petersen, J., Walker, C. S., & Hay, D. L. (2024). Pharmacological characterisation of erenumab, Aimovig, at two calcitonin gene-related peptide responsive receptors. British Journal of Pharmacology, 181, 142-161. doi: 10.1111/bph.16218
Conference Contribution - Published proceedings: Abstract
Hay, D., Rizwan, M., Forrester, L., Rees, T., Rea, B., Sowers, L., … Garelja, M. (2024). Subcutaneous administration of calcitonin-gene related peptide or amylin induces non-evoked pain in female rats. Headache, 64(Suppl. 1), (pp. 13). doi: 10.1111/head.14716
Hay, D., Nimick, M., Garelja, M., Alexander, T., Walker, C., & Banerjee, P. (2024). Pharmacological characterization of ubrogepant and atogepant in cAMP assays at human, rat and mouse calcitonin family receptors in transfected cells. Headache, 64(Suppl. 1), (pp. 11-12). doi: 10.1111/head.14716
Hay, D., Alexander, T., Nimick, M., Garelja, M., Walker, C., & Banerjee, P. (2024). Antagonism by ubrogepant and atogepant of agonist-mediated human CGRP receptor β-arrestin recruitment and internalization in transfected cells. Headache, 64(Suppl. 1), (pp. 3-4). doi: 10.1111/head.14716
Conference Contribution - Verbal presentation and other Conference outputs
Reith, E., Hay, D., & Garelja, M. (2024, August). Characterisation of a naturally occurring calcitonin receptor-like receptor variant. Verbal presentation at the BMS Postgraduate Symposium, Dunedin, New Zealand.
Garelja, M. (2024, December). Investigating the relationship between CGRP and the calcitonin receptor in the brain. Verbal presentation at the Australasian Society of Clinical and Experimental Pharmacologists & Toxicologists (ASCEPT), Asia Pacific Federation of Pharmacologists (APFP), and Australasian Pharmaceutical Science Association (APSA) Joint Congress, Melbourne, Australia.
Hay, D., & Garelja, M. (2024, December). IUPHAR transparency and reproducibility. Workshop presentation at the Australasian Society of Clinical and Experimental Pharmacologists & Toxicologists (ASCEPT), Asia Pacific Federation of Pharmacologists (APFP), and Australasian Pharmaceutical Science Association (APSA) Joint Congress, Melbourne, Australia.
2023
Journal - Research Other
Garelja, M. L., Hay, D., Poyner, D. R., & Walker, C. S. (2023). Calcitonin receptors in GtoPdb v.2023.1 [Citation summary]. IUPHAR/BPS Guide to Pharmacology CITE, (1). doi: 10.2218/gtopdb/F11/2023.1
Conference Contribution - Published proceedings: Abstract
Alexander, T., Garelja, M., & Hay, D. (2023). Differential interaction of β-arrestin with the CGRP and AMY1 receptors. Cephalalgia, 43(1 Suppl.), (pp. 180). doi: 10.1177/03331024231189112
Rees, T., Tasma, Z., Garelja, M., Walker, C., & Hay, D. (2023). The trigeminal and dorsal root ganglia exhibit differences in calcitonin receptor, CGRP, and amylin expression. Cephalalgia, 43(1 Suppl.), (pp. 177). doi: 10.1177/03331024231189112
Forrester, L. M., Garelja, M. L., Dalldorf, L. K., Dawson, A. M., Leen, A. J., Rees, T. A., & Hay, D. L. (2023). Potential paracrine interactions between CGRP and the AMY1 receptor in the parabrachial nucleus and amygdala of rodents. Cephalalgia, 43(1 Suppl.), (pp. 40-41). doi: 10.1177/03331024231189112
Garelja, M. L., Rees, T. A., & Hay, D. L. (2023). Investigation of CGRP and AMY1 receptor subunit expression using RNA-fluorescence in situ hybridization in migraine associated tissue. Cephalalgia, 43(1 Suppl.), (pp. 32-33). doi: 10.1177/03331024231189112
Leen, A. J., Garelja, M. L., Forrester, L. M., & Hay, D. L. (2023). Identifying a new migraine-relevant receptor: Potential paracrine interaction between calcitonin gene-related peptide and the amylin 1 receptor in the parabrachial nucleus. In T. Milne, M. Anwar, L. Burga, H. Harcombe, M. Garelja, A. Middleton, D. C. Ribeiro, N. Fleming, K. Ogbuehi & A. Bahn (Eds.), Proceedings of the 265th Otago Medical School Research Society (OMSRS) Meeting: Summer Student Speaker Awards. Dunedin, New Zealand: OMSRS. Retrieved from https://ourarchive.otago.ac.nz/handle/10523/12839
Conference Contribution - Edited volume of conference proceedings
Milne, T., Anwar, M., Burga, L., Harcombe, H., Garelja, M., Middleton, A., Ribeiro, D. C., Fleming, N., Ogbuehi, K., & Bahn, A. (Eds.). (2023). Proceedings of the 268th Otago Medical School Research Society (OMSRS) Meeting: Masters/Honours/Postgraduate Diploma Student Speaker Awards. Dunedin, New Zealand: OMSRS. Retrieved from https://ourarchive.otago.ac.nz/handle/10523/12839
Milne, T., Anwar, M., Burga, L., Harcombe, H., Garelja, M., Middleton, A., Ribeiro, D. C., Fleming, N., Ogbuehi, K., & Bahn, A. (Eds.). (2023). Proceedings of the 267th Otago Medical School Research Society (OMSRS) Meeting: PhD Student Speaker Speaker Awards. Dunedin, New Zealand: OMSRS. Retrieved from https://ourarchive.otago.ac.nz/handle/10523/12839
Milne, T., Anwar, M., Burga, L., Harcombe, H., Garelja, M., Middleton, A., Ribeiro, D. C., Fleming, N., Ogbuehi, K., & Bahn, A. (Eds.). (2023). Proceedings of the 266th Otago Medical School Research Society (OMSRS) Meeting: Research Staff Speaker Awards. Dunedin, New Zealand: OMSRS. Retrieved from https://ourarchive.otago.ac.nz/handle/10523/12839
Milne, T., Anwar, M., Burga, L., Harcombe, H., Garelja, M., Middleton, A., Ribeiro, D. C., Fleming, N., Ogbuehi, K., & Bahn, A. (Eds.). (2023). Proceedings of the 265th Otago Medical School Research Society (OMSRS) Meeting: Summer Student Speaker Awards. Dunedin, New Zealand: OMSRS. Retrieved from https://ourarchive.otago.ac.nz/handle/10523/12839
2022
Journal - Research Article
Hendrikse, E. R., Rees, T. A., Tasma, Z., Garelja, M. L., Siow, A., Harris, P. W. R., … Hay, D. L. (2022). Characterization of antibodies against receptor activity-modifying protein 1 (RAMP1): A cautionary tale. International Journal of Molecular Sciences, 23, 16035. doi: 10.3390/ijms232416035
Garelja, M. L., & Hay, D. L. (2022). A narrative review of the calcitonin peptide family and associated receptors as migraine targets: Calcitonin gene-related peptide and beyond. Headache, 62(9), 1093-1104. doi: 10.1111/head.14388
Garelja, M. L., Bower, R. L., Brimble, M. A., Chand, S., Harris, P. W. R., Jamaluddin, M. A., … Hay, D. L. (2022). Pharmacological characterisation of mouse calcitonin and calcitonin receptor-like receptors reveals differences compared to human receptors. British Journal of Pharmacology, 179, 416-434. doi: 10.1111/bph.15628
Conference Contribution - Edited volume of conference proceedings
Wilson, L., Harcombe, H., Jayakaran, P., Burga, L., Antony, J., Morgaine, K., Garelja, M., Middleton, A., Anwar, M., & Milne, T. (Eds.). (2022). Proceedings of the 264th Otago Medical School Research Society (OMSRS) Meeting: Masters/Honours Student Speaker Awards. Dunedin, New Zealand: OMSRS. Retrieved from https://ourarchive.otago.ac.nz/handle/10523/12839
Wilson, L., Harcombe, H., Jayakaran, P., Burga, L., Antony, J., Morgaine, K., Garelja, M., Middleton, A., Anwar, M., & Milne, T. (Eds.). (2022). Proceedings of the 263rd Otago Medical School Research Society (OMSRS) Meeting: PhD Student Speaker Awards. Dunedin, New Zealand: OMSRS. Retrieved from https://ourarchive.otago.ac.nz/handle/10523/12839
Wilson, L., Harcombe, H., Jayakaran, P., Burga, L., Antony, J., Morgaine, K., Garelja, M., Middleton, A., Anwar, M., & Milne, T. (Eds.). (2022). Proceedings of the 262nd Otago Medical School Research Society (OMSRS) Meeting: Research Staff Speaker Awards. Dunedin, New Zealand: OMSRS. Retrieved from https://ourarchive.otago.ac.nz/handle/10523/12839
Conference Contribution - Verbal presentation and other Conference outputs
Alexander, T. I., Garelja, M. L., Gingell, J. J., & Hay, D. L. (2022, September). Differential interaction of β-arrestin for two CGRP-responsive receptors. Verbal presentation at the Postgraduate & Early Career Researchers Committee (PERC) & Division of Health Sciences Early & Mid-Career Researcher (EMCR) Joint Research Symposium, Dunedin, New Zealand.
Garelja, M. L., Alexander, T., Walker, C. S., & Hay, D. L. (2022, August-September). Extracellular bimolecular fluorescence complementation assays for investigating receptor dimerization: A proof of concept with receptors for calcitonin gene-related peptide. Verbal presentation at the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) NZ Annual Scientific Meeting, Queenstown, New Zealand.
2021
Journal - Research Other
Garelja, M. L., Walker, C. S., & Hay, D. L. (2021). CGRP receptor antagonists for migraine: Are they also AMY1 receptor antagonists? British Journal of Pharmacology, 179, 454-459. doi: 10.1111/bph.15585
Conference Contribution - Published proceedings: Abstract
Garelja, M., Walker, C., & Hay, D. (2021). Pharmacological characterisation of mouse calcitonin and calcitonin receptor-like receptors reveals differences compared to human receptors. Cephalalgia, 41(1 Suppl.), (pp. 72). doi: 10.1177/03331024211034005
Conference Contribution - Verbal presentation and other Conference outputs
Garelja, M. (2021, December). CGRP blocking drugs for migraine: Towards a better understanding of mechanisms of action. Verbal presentation at the Pain@Otago Research Symposium, [Online].
2020
Journal - Research Article
Garelja, M. L., Au, M., Brimble, M. A., Gingell, J. J., Hendrikse, E. R., Lovell, A., … Hay, D. L. (2020). Molecular mechanisms of class B GPCR activation: Insights from adrenomedullin receptors. ACS Pharmacology & Translational Science, 3(2), 246-262. doi: 10.1021/acsptsci.9b00083
2019
Journal - Research Article
Musa, H., Hendrikse, E. R., Brimble, M. A., Garelja, M. L., Watkins, H. A., Harris, P. W. R., & Hay, D. L. (2019). Pharmacological characterization and investigation of N-terminal loop amino acids of adrenomedullin 2 that are important for receptor activation. Biochemistry, 58(32), 3468-3474. doi: 10.1021/acs.biochem.9b00571
Yule, L. R., Garelja, M. L., Hendrikse, E. R., Gingell, J. J., Poyner, D. R., Harris, P. W. H., Brimble, M. A., & Hay, D. L. (2019). A potent fluorescent calcitonin gene-related peptide analogue enables visualization of receptor internalization. Peptide Science, 111(6), e2416. doi: 10.1002/pep2.24126
Awarded Doctoral Degree
Garelja, M. (2019). Molecular insights into the signalling of calcitonin receptor-like receptor: Receptor activity-modifying protein complexes (PhD). University of Auckland, Auckland, New Zealand. Retrieved from http://hdl.handle.net/2292/50390
2018
Journal - Research Article
Garelja, M. L., Walker, C. A., Siow, A., Yang, S. H., Harris, P. W. R., Brimble, M. A., … Hay, D. L. (2018). Receptor activity modifying proteins have limited effects on the class B G protein-coupled receptor calcitonin receptor-like receptor stalk. Biochemistry, 57(8), 1410-1422. doi: 10.1021/acs.biochem.7b01180
Simms, J., Uddin, R., Sakmar, T. P., Gingell, J. J., Garelja, M. L., Hay, D. L., … Poyner, D. R. (2018). Photoaffinity cross-linking and unnatural amino acid mutagenesis reveal insights into calcitonin gene-related peptide binding to the CalcitoninRreceptor-Like Receptor/Receptor Activity-Modifying Protein 1 (CLR/RAMP1) complex. Biochemistry, 57(32), 4915-4922. doi: 10.1021/acs.biochem.8b00502
Journal - Research Other
Hay, D. L., Garelja, M. L., Poyner, D. R., & Walker, C. S. (2018). Update on the pharmacology of calcitonin/CGRP family of peptides: IUPHAR Review 25. British Journal of Pharmacology, 175(1), 3-17. doi: 10.1111/bph.14075
Conference Contribution - Published proceedings: Abstract
Walker, C. S., Garelja, M., Rees, T. A., & Hay, D. (2018). Profiling calcitonin gene-related peptide receptor dignalling in transfected cells and trigeminal ganglia neurons. Headache, 58(Suppl. 2), (pp. 69-70). doi: 10.1111/head.13306
2017
Journal - Research Article
Woolley, M. J., Reynolds, C. A., Simms, J., Walker, C. S., Mobarec, J. C., Garelja, M. L., … Hay, D. L. (2017). Receptor activity-modifying protein dependent and independent activation mechanisms in the coupling of calcitonin gene-related peptide and adrenomedullin receptors to Gs. Biochemical Pharmacology, 142, 96-110. doi: 10.1016/j.bcp.2017.07.005
2016
Journal - Research Article
Watkins, H. A., Chakravarthy, M., Abhayawardana, R. S., Gingell, J. J., Garelja, M. L., Pardamwar, M., … Hay, D. L. (2016). Receptor activity-modifying proteins 2 and 3 generate adrenomedullin receptor subtypes with distinct molecular properties. Journal of Biological Chemistry, 291(22), 11657-11675. doi: 10.1074/jbc.M115.688218